Another look at granulocyte transfusions in neutropenic patients with cancer

Infections in Medicine

Volumn 13, Issue 2, 1996, Pages

  Lucas, Kenneth G ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Infection, fungal; Neutropenia; Sepsis; Transfusion

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; BACTERIAL INFECTION; CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRANULOCYTE TRANSFUSION; HUMAN; MAJOR CLINICAL STUDY; MYCOSIS; NEUTROPENIA; SURVIVAL;

EID: 0029870385     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bodey GP, Buckley M, Sathe YS, et al: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340, 1966.
2. Weinberger M, Elattar I, Marshall D, et al: Patterns of infection in patients with aplastic anemia and the emergence of aspergillosis as a major cause of death. Medicine 71:24-43, 1992.
3. Denning DW, Stevens DA: Antifungal and surgical treatment of invasive aspergillosis: A review of 2121 published cases. Rev Infect Dis 12:1147-1184, 1990.
4. Pizzo PA, Hathorn JW, Heimenz J, et al: A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 315:552-558, 1986.
5. Shenep JL, Hughes WT, Roberson PK, et al: Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med 319:1053-1058, 1988.
6. Burch PA, Karp JE, Merz WG, et al: Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol 15:1985-1993, 1987.
7. Young RC, Bennet JE, Vogel CL, et al: Aspergillosis. The spectrum of disease in 98 patients. Medicine 49:147-173, 1970.
8. Aisner J, Schimpff SC, Wiernik PH: Treatment of invasive aspergillosis: Relation of early diagnosis and treatment to response. Ann Intern Med 86:539-543, 1977.
9. Pennington JE: Aspergillus pneumonia in hematologic malignancy. Improvements in diagnosis and therapy. Arch Intern Med 137:769-771, 1977.
10. Epstein RB, Waxman FJ, Benett BT, et al: Pseudomonas septicemia in leukopenic dogs. I. Treatment with granulocyte transfusions. Transfusion 14:51-57, 1974.
11. Appelbaum FR, Bowles CA, Makuch RW, et al: Granulocyte transfusion therapy of experimental Pseudomonas septicemia: Study of cell dose and collection technique. Blood 52:323-331, 1978.
12. Cairo MS, Worcester CC, Rucker RW, et al: Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr 120:281-285, 1992.
13. Freireich EJ, Levin RH, Whang J, et al: The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann NY Acad Sci 113:1081-1089, 1964.
14. Graw RG Jr, Herzig G, Perry S, et al: Normal granulocyte transfusion therapy. Treatment of septicemia due to gram-negative bacteria. N Engl J Med 287:367-371, 1972.
15. Fortuny IE, Bloomfield CD, Hadlock DC, et al: Granulocyte transfusion: A controlled study in patients with acute nonlymphocytic leukemia. Transfusion 15:548-558, 1975.
16. Vogler WR, Winton EF: A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 63:548-555, 1977.
17. Alavi JB, Root RK, Djerassi I, et al: A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 296:706-711, 1977.
18. Higby DJ, Yates JW, Henderson ES, et al: Filtration leukapheresis for granulocyte transfusion therapy. N Engl J Med 292:761-766, 1975.
19. Winston DJ, Ho WG, Gale RP: Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 97:509-518, 1982.
20. Herzig RH, Herzig GP, Graw RG, et al: Successful granulocyte transfusion therapy for gramnegative septicemia. A prospectively randomized controlled study. N Engl J Med 296:701-705, 1977.
21. Clift RA, Sanders JE, Thomas ED, et al: Granulocyte transfusions for the prevention of infection in patients receiving bone marrow transplants. N Engl J Med 298:1052-1057, 1978.
22. Clarke K, Szer J, Shelton M, et al: Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection. Bone Marrow Transplant 16:723-726, 1995.
23. Heustis DW, Glasser L: The neutrophil in transfusion medicine. Transfusion 34:630-646, 1994.
24. Klein HG (ed): Standards for blood banks and transfusion services, ed 16. Bethesda, American Association of Blood Banks, 1993, p 13.
25. Bensinger WI, Price TH, Dale DC, et al: The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81:1883-1888, 1993.
26. Caspar CB, Seeger RA, Burger J, et al: Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 81:2866-2871, 1993.
27. Strauss RG: Therapeutic granulocyte transfusions in 1993. Blood 81:1675-1678, 1993.
28. Wade PH, Skrabut EH, Vinciguerra L, et al: In vitro function of granulocytes isolated from blood of normal volunteers using continuous-flow centrifugation in the IBM-Aminco centrifuge and adhesion-filtration leukapheresis using nylon fiber. Transfusion 17:136-140, 1977.
29. McCullough J, Weiblen BJ, Deinard AR, et al: In vitro function and post-transfusion survival of granulocytes collected by continuous-flow centrifugation and filtration leukapheresis. Blood 48:315-326, 1976.
30. McCullough J, Weiblen BJ, Peterson PK, et al: Effect of temperature on granulocyte preservation. Blood 52:301-310, 1978.
31. Jurecka W, Sz'epfalusi Z, Parth E, et al: Hydroxyethylstarch deposits in human skin: A model for pruritus? Arch Dermatol Res 285:13, 1993.
32. Ward HN: Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 73:689-694, 1970.
33. Goldstein IM, Eyre HJ, Terasaki PI, et al: Leukocyte transfusions: Role of leukocyte alloantibodies in determining transfusion response. Transfusion 11:19-24, 1971.
34. Appelbaum FR, Trapani RJ, Graw RG Jr: Consequences of prior alloimmunization during granulocyte transfusion. Transfusion 17:460-464, 1977.
35. Ungerleider RS, Appelbaum FR, Trapani RJ, et al: Lack of predictive value of antileukocyte antibody screening in granulocyte transfusion therapy. Transfusion. 19:90-94, 1979.
36. Wright DG, Robichaud KJ, Pizzo PA, et al: Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 304:1185-1189, 1981.
37. Bow EJ, Schroeder ML, Louie TJ: Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B. Can Med Assoc J 130:594-597, 1984.
38. Haber RH, Oddone EZ, Gurbel PA, et al: Acute pulmonary decompensation due to amphotericin B in the absence of granulocyte transfusions (letter). N Engl J Med 315:836, 1986.
39. Dana BW, Durie BG, White RF, et al: Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: Absence of significant pulmonary toxicity. Blood 57:90-94, 1981.
40. Dutcher JP, Kendall J, Norris D, et al: Granulocyte transfusion therapy and amphotericin B: adverse reactions? Am J Hematol 31:102-108, 1989.